Clinical trial
Sestrin-2 Levels and Insulin Resistance in Childhood Obesity
NCT06779721 is registered in ClinicalTrials.gov with Kayseri City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sestrin-2 Levels and Insulin Resistance in Childhood Obesity
- Lead sponsor
- Kayseri City Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 20, 2021
- Completion date
- February 15, 2022
- Enrollment
- 89 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obese adolescents